Cargando…
P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428921/ http://dx.doi.org/10.1097/01.HS9.0000969496.68553.26 |
| _version_ | 1785090586469990400 |
|---|---|
| author | Lansigan, Frederick A. Eyre, Toby Ghosh, Nilanjan S. Manzoor, Beenish C. Coombs, Catherine Lamanna, Nicole H. Tuncer, Hande Emechebe, Dozie R. Brown, Jennifer E. Roeker, Lindsey Ujjani, Chaitra Alhasani, Hasan Fleury, Isabelle A. Leslie, Lori Skarbnik, Alan Rhodes, Joanna T. Hill, Brian M. Barr, Paul S. Davids, Matthew P. Fox, Christopher Choi, Yun Schuh, Anna Kennard, Kaitlin E. Jensen, Christopher Jawaid, Dureshahwar Sharma, Aditya Pivneva, Irina Watson, Talissa Shadman, Mazyar |
| author_facet | Lansigan, Frederick A. Eyre, Toby Ghosh, Nilanjan S. Manzoor, Beenish C. Coombs, Catherine Lamanna, Nicole H. Tuncer, Hande Emechebe, Dozie R. Brown, Jennifer E. Roeker, Lindsey Ujjani, Chaitra Alhasani, Hasan Fleury, Isabelle A. Leslie, Lori Skarbnik, Alan Rhodes, Joanna T. Hill, Brian M. Barr, Paul S. Davids, Matthew P. Fox, Christopher Choi, Yun Schuh, Anna Kennard, Kaitlin E. Jensen, Christopher Jawaid, Dureshahwar Sharma, Aditya Pivneva, Irina Watson, Talissa Shadman, Mazyar |
| author_sort | Lansigan, Frederick |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428921 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289212023-08-17 P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY Lansigan, Frederick A. Eyre, Toby Ghosh, Nilanjan S. Manzoor, Beenish C. Coombs, Catherine Lamanna, Nicole H. Tuncer, Hande Emechebe, Dozie R. Brown, Jennifer E. Roeker, Lindsey Ujjani, Chaitra Alhasani, Hasan Fleury, Isabelle A. Leslie, Lori Skarbnik, Alan Rhodes, Joanna T. Hill, Brian M. Barr, Paul S. Davids, Matthew P. Fox, Christopher Choi, Yun Schuh, Anna Kennard, Kaitlin E. Jensen, Christopher Jawaid, Dureshahwar Sharma, Aditya Pivneva, Irina Watson, Talissa Shadman, Mazyar Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428921/ http://dx.doi.org/10.1097/01.HS9.0000969496.68553.26 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Lansigan, Frederick A. Eyre, Toby Ghosh, Nilanjan S. Manzoor, Beenish C. Coombs, Catherine Lamanna, Nicole H. Tuncer, Hande Emechebe, Dozie R. Brown, Jennifer E. Roeker, Lindsey Ujjani, Chaitra Alhasani, Hasan Fleury, Isabelle A. Leslie, Lori Skarbnik, Alan Rhodes, Joanna T. Hill, Brian M. Barr, Paul S. Davids, Matthew P. Fox, Christopher Choi, Yun Schuh, Anna Kennard, Kaitlin E. Jensen, Christopher Jawaid, Dureshahwar Sharma, Aditya Pivneva, Irina Watson, Talissa Shadman, Mazyar P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY |
| title | P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY |
| title_full | P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY |
| title_fullStr | P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY |
| title_full_unstemmed | P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY |
| title_short | P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY |
| title_sort | p648: real-world treatment and outcomes of patients with chronic lymphocytic leukemia (cll) receiving first-line (1l) therapy in the novel agent era: an international study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428921/ http://dx.doi.org/10.1097/01.HS9.0000969496.68553.26 |
| work_keys_str_mv | AT lansiganfrederick p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT aeyretoby p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT ghoshnilanjan p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT smanzoorbeenish p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT ccoombscatherine p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT lamannanicole p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT htuncerhande p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT emechebedozie p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT rbrownjennifer p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT eroekerlindsey p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT ujjanichaitra p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT alhasanihasan p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT fleuryisabelle p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT aleslielori p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT skarbnikalan p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT rhodesjoanna p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT thillbrian p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT mbarrpaul p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT sdavidsmatthew p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT pfoxchristopher p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT choiyun p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT schuhanna p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT kennardkaitlin p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT ejensenchristopher p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT jawaiddureshahwar p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT sharmaaditya p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT pivnevairina p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT watsontalissa p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy AT shadmanmazyar p648realworldtreatmentandoutcomesofpatientswithchroniclymphocyticleukemiacllreceivingfirstline1ltherapyinthenovelagenteraaninternationalstudy |